Related references
Note: Only part of the references are listed.PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2011)
Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells
Eduardo L. M. Guimaraes et al.
JOURNAL OF HEPATOLOGY (2010)
Role of the receptor for advanced glycation end products in hepatic fibrosis
Christina Lohwasser et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats
Jin-Rong Xia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells
Keiko Iwamoto et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis
Chandana B. Herath et al.
JOURNAL OF HEPATOLOGY (2007)
Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia
An S. De Vriese et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
RAGE control of diabetic nephropathy in a mouse model -: Effects of RAGE gene disruption and administration of low-molecular weight heparin
Khin-Mar Myint et al.
DIABETES (2006)
TAGE (toxic AGEs) theory in diabetic complications
Takashi Sato et al.
CURRENT MOLECULAR MEDICINE (2006)
Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products
Vedat Schwenger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
R Ramasamy et al.
GLYCOBIOLOGY (2005)
Advanced glycation endproducts - role in pathology of diabetic complications
N Ahmed
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
LA Adams et al.
JOURNAL OF HEPATOLOGY (2005)
Advanced glycoxidation end products in commonly consumed foods
T Goldberg et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2004)
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α -: Dependent pathway
V Thallas-Bonke et al.
DIABETES (2004)
Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis
JA Dranoff et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2004)
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes
R Candido et al.
CIRCULATION RESEARCH (2003)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Fibrogenic impact of high serum glucose in chro nic hepatitis C
V Ratziu et al.
JOURNAL OF HEPATOLOGY (2003)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts
H Fehrenbach et al.
HEPATOLOGY (2001)
Advanced glycation end-products: a review
R Singh et al.
DIABETOLOGIA (2001)
Share Paper
